12 slides from Wuxi Apptec Co., Ltd. Class A's investor day presentation, 2025
Slide 1: CRDMO: Driving Sustainable Financial Strength
2025 WuXi AppTec Investor Day CRDMO: Driving Sustainable Financial Strength Florence Shi Chief Financial Officer 1 603259.SH / 2359.HK
Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation may contain certain statements that are or may be forward looking, which can be recognized by the use of words such as “expects”, “plans”, “will”, “estimates”, “projects”, “intends”, or words of similar meaning. Such forward-looking statements are not his
Slide 3: Accelerating Growth Beyond Industry Momentum
Accelerating Growth Beyond Industry Momentum CRDMO Drives 3x Market Outperformance 3x WXAT Rev CAGR +24% 2x WXAT Rev CAGR WXAT Rev Reached +23% NBI CAGR RMB 1.0Bn in 2007 +8% NBI CAGR NBI CAGR +12% -5% 2000 2007 2012 2018 2025E NASDAQ Biotech Index (NBI), Bloomberg, 2000/01/01-2025/09/24 3
Slide 4: Expanding Competitive Advantage Through a Unique Value Proposition
Expanding Competitive Advantage Through a Unique Value Proposition Seven - Year Track Record with Ongoing Momentum +7% +23% +32% +4% +37% +13% +15% +11% 2018 2019 2020 2021 2022 2023 2024 1H’25 5 China Competitors‘ Revenue Combined 1) WuXi AppTec Revenue 4 1) 5 Top China Competitors in CRO & CDMO se
Slide 5: Powering Rapid "D&M" Growth through Stronger "R" Capabilities
Powering Rapid “D&M” Growth through Stronger “R” Capabilities 38% Backlog Growth with 55% D&M Backlog Growth 2x “R” Orders Amplifies 17x “D&M” Orders (RMB in Bn) 56.7 49.3 +38% 33.3 27.9 31.1 14x 17x 14.8 8x 10.9 7.0 2x 2018 2019 2020 2021 2022 2023 2024 1H’25 D&M Backlog R Backlog 1) 5 1) Continuin
Slide 6: Delivering Industry Insights for Optimal Capacity Planning to Secure High-Value Opportunities
Delivering Industry Insights for Optimal Capacity Planning to Secure High- Value Opportunities Adj. Non-IFRS New GP% @ CER1) 41% 41% 41% 40% 42% 42% 42% High 45 1H’25 45% 40 35 30 25 D&M Capex Spending Portion 20 15 Increased from 28% to ~85% 10 5 0 2018 2019 2020 2021 2022 2023 2024 2025E Establish
Slide 7: Maintaining Organizational Agility and Elevating Operational Efficiency
Maintaining Organizational Agility and Elevating Operational Efficiency Doubling Per - Capita Productivity 50% Reduction in SG&A Ratio 1,118 -50% 15.3% 14.9% 14.7% 12.7% 9.0% 9.2% 8.9% 7.5% 2x 542 2018 2019 2020 2021 2022 2023 2024 2025E 2018 2019 2020 2021 2022 2023 2024 1H’25 WuXi AppTec Per Capit
Slide 8: Proven Resilient Profitability Through the CRDMO Model, Operating Strategy and Outstanding Execution
Proven Resilient Profitability Through the CRDMO Model, Operating Strategy and Outstanding Execution New Adj. Non-IFRS NI% 18% 18% 22% 22% 24% 27% 27% High 1H’25 30% Revenue CAGR 24% vs Adj. Non-IFRS NI CAGR 30%+ 10.9 10.6 9.4 5.1 3.6 1.7 2.3 Adj. Non-IFRS NI (RMB in Bn) 2018 2019 2020 2021 2022 202
Slide 9: Fueling Robust Operating Cash Flow Through the CRDMO Model and Efficiency Gains
Fueling Robust Operating Cash Flow Through the CRDMO Model and Efficiency Gains 2.4x 35% 31% 31% 26% 23% 20% 19% 12.6 12.0 16% 10.2 3.8 4.4 2.5 1.5 2018 2019 2020 2021 2022 2023 2024 2025E WuXi AppTec - IFRS OCF (RMB in Bn) OCF Ratio = OCF / Revenue 9
Slide 10: Enabling Value Creation and Consistent Shareholder Returns
Enabling Value Creation and Consistent Shareholder Returns Continuously Improved EPS Total RMB 20Bn Dividends & Share Buybacks Basic Earning Per Share 12 Dividend Payout & Share Buybacks for Cancellation 10 6 5 ~7x 8 7.1 6.8 4 6 2.0 3.0 3.3 3.3 4.2 3 4 2 1.8 1.1 4.8 2 1 0.7 2.6 2.9 0.9 1.5 0 0 0.7 0
Slide 11: Outperforming Total Shareholder Return
Outperforming Total Shareholder Return Total Shareholder Return (TSR) total return in 7 years • WuXi AppTec: 12.3x • CXO index: China 3.3x / & Global 1.5x • Biotech: Nasdaq 1.7x / S&P 1.2x • Healthcare index: S&P 1200 Health Index 2.0x Total Shareholder Return from 2018/5/8 to 2025/9/24 11 Source: B
Slide 12: Steering Next 25 Years with Our Unique CRDMO
Steering Next 25 Years with Our Unique CRDM“O” Expanding Competitive Advantage Through Our Unique CRDMO Business Model 01 02 Delivering In-depth Industry Insights to Secure High-Value Opportunities 03 Maintaining Organizational Agility and Elevating Operational Efficiency 04 Sustaining Resilient Pro